SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:liu-187514"
 

Sökning: onr:"swepub:oai:DiVA.org:liu-187514" > Adverse events duri...

  • Eriksson, VictoriaUmeå universitet,Urologi och andrologi,Umea Univ, Sweden (författare)

Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer - a Swedish retrospective multicentre study of a clinical database

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022-08
  • AME Publishing Company,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-187514
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-187514URI
  • https://doi.org/10.21037/tau-22-78DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-199325URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|Swedish Research Council [Bas-ALF/VLL RV-848051]; Cancer Research Foundation in Norrland, Umea, Sweden [CFF LP 13-2000]
  • Background: Adverse events (AEs) during neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC) are known but insufficiently reported. Clinical implications include affected cardiac, pulmonary, urinary, vascular and haematological organ systems. The main purpose was to evaluate the incidence and severity of AEs for ascertaining possible clinical significance. Further investigating possible effects of AEs on downstaging outcomes-downstaging is considered a surrogate marker for overall survival (OS).Methods: A retrospective evaluation of AEs during ongoing NAC for MIBC patients analysing individual patient data in a clinical database. We identified 687 cystectomies between 2009-2020 at four Swedish urological centres. Inclusion criteria were cT2-4aN0M0 in 261 NAC patients undergoing radical cystectomy (RC). Medical files were reviewed and AEs were assessed and graded, including detailed measurements by the Common Terminology Criteria for Adverse Events (CTCAE) v.5. Data were retrospectively analysed in SPSS statistics 27.0 with Spearman rank-order correlation coefficient and Mann-Whitney U-test (MWU).Results: A total of 251/261 patients [95% confidence interval (CI), 93-98%] experienced AEs during NAC pre-RC (mean two AEs/patient). In total, 208 (80%) patients received methotrexate, vinblastine, adriamycin (doxorubicin) and cisplatin (MVAC). In the total cohort, 200 (76.6%) received all pre-planned NAC-cycles. Most common AEs were anaemia (88.9%), thrombocytopenia (44.8%) and acute kidney injury (40.6%). Patients with prematurely terminated cycles had higher AE-grades (P=0.042 MWU). A correlation between higher AE-grades and decrease in downstaging existed, in the entire cohort (-0.133; P=0.033) and in patients undergoing all pre-planned NAC-cycles (-0.148; P=0.038). Anaemia and acute kidney injury were individually associated with decreased downstaging (-0.360, P=0.025 and -0.183, P=0.010, respectively).Conclusion: NAC in MIBC poses a significant risk for AEs before RC with clinical implications. For instance, patients terminating chemotherapy prematurely, have higher AE-grades and decreased downstaging. Further, acute kidney injury and anaemia are individually associated with decreased downstaging. We propose that early detection and prevention of AEs may increase downstaging of the primary tumour.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Holmlund, JennieUmeå universitet,Urologi och andrologi,Umea Univ, Sweden (författare)
  • Wiberg, ErikUmeå universitet,Urologi och andrologi,Umea Univ, Sweden(Swepub:umu)erwi0035 (författare)
  • Johansson, MarkusUmeå universitet,Urologi och andrologi,Umea Univ, Sweden (författare)
  • Huge, YlvaLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland,Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden(Swepub:liu)ylvhu61 (författare)
  • Alamdari, FarhoodVastmanland Hosp, Sweden,Department of Urology, Västmanland Hospital, Västerås, Sweden (författare)
  • Svensson, Johan,1978-Umeå universitet,Statistik,Umea Univ, Sweden(Swepub:umu)josv0027 (författare)
  • Aljabery, FirasLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland,Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden(Swepub:liu)firab05 (författare)
  • Sherif, AmirUmeå universitet,Urologi och andrologi,Umea Univ, Sweden; Umea Univ, Sweden(Swepub:umu)amsh0008 (författare)
  • Umeå universitetUrologi och andrologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Translational Andrology and Urology: AME Publishing Company11:8, s. 1105-11152223-46832223-4691

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy